Core Laboratories/CLB

$22.03

-2.13%
-
1D1W1MYTD1YMAX

About Core Laboratories

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. It provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. It provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.
Ticker
CLB
Sector
Energy
Trading on
NYSE
Industry
Oil Well Services & Equipment
CEO
Lawrence Bruno
Employees
3,600
Headquarters
Amstelveen, Netherlands

CLB Metrics

BasicAdvanced
$1.03B
Market cap
43.58
P/E ratio
$0.51
EPS
2.67
Beta
$0.04
Dividend rate
0.18%
Dividend yield

What the Analysts think about CLB

Analyst Ratings

Majority rating from 8 analysts.
Hold

Price Targets

Average projection from 8 analysts.
7.49% downside
High $31.00
Low $16.00
$22.03
Current price
$20.38
Average price target

CLB Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
1.79% profit margin
QuarterlyAnnual
Q1 23
QoQ growth
Revenue
$128.3M
0.63%
Net income
$2.3M
-65.67%
Profit margin
1.79%
-65.9%

CLB Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 19.39%
QuarterlyAnnual
Q2 22
Q3 22
Q4 22
Q1 23
Q2 23
Actual
$0.12
$0.18
$0.20
$0.19
-
Expected
$0.14
$0.15
$0.20
$0.16
$0.21
Surprise
-12.01%
20.34%
2.19%
19.39%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Core Laboratories stock

Buy or sell Core Laboratories stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing